DAILY MORNING NOTE | 13 April 2023

Trade of the Day

Del Monte Pacific Ltd (SGX: D03)

Analyst: Zane Aw

(Current Price: S$0.240) – TECHNICAL BUY
Buy price: S$0.240 Stop loss: S$0.230
Take profit 1: S$0.275 Take profit 2: S$0.290

Broadcom Inc. (NASDAQ: AVGO)

Analyst: Zane Aw

(Current Price: US$621.57) – TECHNICAL SELL
Sell price: US$621.57 Stop loss: US$644.00 Take profit: US$546.00

Singapore shares fell 0.4 per cent or 11.71 points to close at 3,286.12 points on Wednesday (Apr 12), as key markets across Asia saw mixed trading. In the wider Singapore market, losers edged out gainers 282 to 260, with 1.2 billion securities worth S$870.2 million traded. The Shanghai Composite Index, South Korea’s Kospi and Japan’s Nikkei 225 rose between 0.1 per cent and 0.6 per cent, while Hong Kong’s Hang Seng Index and the FTSE Bursa Malaysia KLCI fell between 0.1 per cent and 0.9 per cent

Wall Street stocks finished a volatile session lower Wednesday (Apr 12) after minutes showed US Federal Reserve economists in March projected a “mild recession”. Equities resumed a downward track following the afternoon disclosure, which shed light on the central bank’s Mar 22 decision. The Dow Jones Industrial Average edged down 0.1 per cent to 33,646.50. The broad-based S&P 500 declined 0.4 per cent to 4,091.95, while the tech-rich Nasdaq Composite dropped 0.9 per cent to 11,929.34.

Top gainers & losers





Singapore Exchange Regulation (SGX RegCo) on Wednesday (Apr 12) issued a “trade with caution” alert on Digilife Technologies, after its share price rose by 157 per cent or S$1.76, from S$1.12 on Jan 6 to S$2.88 on Apr 11. It said that between Mar 1 and Apr 11, Digilife Tech’s share buybacks contributed to about 70.6 per cent of the stock’s buy volume. In that period, the stock’s share price rose S$1.08 or 60 per cent, from S$1.80 to S$2.88.

Meta Health, on April 12, announced that it has lodged a police report against Dr Vas Metupalle, who is the chief medical officer of its wholly-owned subsidiary 5Digital. The police report was lodged on the same day as Metupalle’s termination. In its filing, Meta Health stated that it had “reasonable grounds” to believe that Metupalle had deceived or sought to deceive 5Digital and the group after conducting its own investigations. While investigations by the police are still ongoing, Meta Health expects the allegations to have a “material negative impact” on its financial statements for the FY2022 ended Dec 31, 2022.

Beng Kuang Marine has entered into a conditional land sale & purchase agreement to sell a part of its Batam waterfront shipyard property for $8.64 million to a subsidiary of Oil States Industries, a major global provider of integrated energy systems and solutions. In the recent years, the group has been prioritising cost minimisation and deleveraging initiatives, while focusing on monetising fixed assets and high-potential business segments within its core business divisions to create new growth catalysts.


Inflation cooled in March as the Federal Reserve’s interest rate increases showed more impact, the Labor Department reported Wednesday. The consumer price index, a widely followed measure of the costs for goods and services in the U.S. economy, rose 0.1% for the month against a Dow Jones estimate for 0.2%, and 5% from a year ago versus the estimate of 5.1%. Excluding food and energy, the core CPI increased 0.4% and 5.6% on an annual basis, both as expected.

Shares of the major airline companies were under pressure on Wednesday after American Airlines updated its first-quarter guidance. American said it expected adjusted earnings per share of 1 cent to 5 cents for the quarter, according to a filing with the Securities and Exchange Commission. That is above prior guidance of breakeven, but the average analyst projection was for 5 cents. Shares of American fell more than 9% on April 12.

Oil prices rose 2 per cent on Wednesday (Apr 12) as cooling US inflation data spurred hopes that the Federal Reserve is getting closer to ending its cycle of interest-rate hikes and cushioned the impact of a small build in US crude oil stocks. Brent crude settled up US$1.72, or 2.01 per cent, at US$87.33 a barrel while US West Texas Intermediate closed up US$1.73, or 2.1 per cent, to US$83.26. Prices rose about 2 per cent on Tuesday.

Source: SGX Masnet, Bloomberg, Channel NewsAsia, Reuters, CNBC, WSJ, The Business Times, PSR


PSR Stocks Coverage



For more information, please visit:


Upcoming Webinars

Guest Presentation by MindChamp PreSchool Limited [NEW]

Date: 18 April 2023

Time: 1pm – 2pm

Register: https://bit.ly/3Kc5bJl

Guest Presentation by Sabana Industrial REIT [NEW]

Date: 19 April 2023

Time: 12pm – 1pm

Register: https://bit.ly/3Gm29kD

Guest Presentation by KTMG Limited [NEW]

Date: 25 April 2023

Time: 12pm – 1pm

Register: https://bit.ly/3U87u4P

Guest Presentation by OUE Commercial REIT [NEW]

Date: 10 May 2023

Time: 12pm – 1pm

Register: https://bit.ly/3GzrdF3

POEMS Podcast:

Research Videos

Weekly Market Outlook: Technical Analysis, US 2Q 2023 Equity Strategy
Date: 10 April 2023
Click here for more on Market Outlook.
Sign up for our webinars here, and be among the first to receive economy and market updates.


Phillip Research in 3 minutes: #29 Keppel Corporation; Initiation
Click here for more on Phillip in 3 mins.

Follow our Socials

Facebook Social Icon Instagram Icon Twitter Social Icon Youtube Social Icon Linkedin Social Icon TikTok Social Icon Spotify Social Icon

Join our Singapore Equity Research Community on POEMS Mobile 3 App for the latest research reports, market updates, insights and more

Click to join!


The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided 揳s is?without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.

Confidentiality Note

This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com